TGF-beta/Smad
Find Products by Targets
Isoform-selective Inhibitors
- ALK2 selective inhibitors
- TGF-β selective s
- TGFβRI/ALK5 selective inhibitors
- Abl selective inhibitors
- ROCK2 selective inhibitors
-
Choose Your Country or Region
- Australia
- Austria
- Argentina
- Belgium
- Canada
- China
- Czech Republic
- Denmark
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- India
- Ireland
- Israel
- Italy
- Japan
- Korea
- Luxembourg
- Malaysia
- Mexico
- Netherlands
- New Zealand
- Norway
- Poland
- Romania
- Russia
- Saudi Arabia
- Singapore
- South Africa
- Spain
- Sweden
- Switzerland
- Taiwan
- Turkey
- United Kingdom
- United States
- Other Countries
New PD-1/PD-L1 therapeutic antibodies (Pembrolizumab, Atezolizumab and Nivolumab) release!
- Home
- Inhibitors
By Signaling Pathways
- PI3K/Akt/mTOR
- Epigenetics
- Methylation
- Immunology & Inflammation
- Protein Tyrosine Kinase
- Angiogenesis
- Apoptosis
- Autophagy
- ER stress & UPR
- JAK/STAT
- MAPK
- Cytoskeletal Signaling
- Cell Cycle
- TGF-beta/Smad
- DNA Damage
- Stem Cells & Wnt
- Ubiquitin
- Neuronal Signaling
- NF-κB
-
GPCR & G Protein
- 5-HT Receptor
- Adrenergic Receptor
- Histamine Receptor
- Dopamine Receptor
- Opioid Receptor
- Cannabinoid Receptor
- Endothelin Receptor
- S1P Receptor
- Hedgehog/Smoothened
- SGLT
- LPA Receptor
- OX Receptor
- CGRP Receptor
- MT Receptor
- PAFR
- PKA
- CaSR
- cAMP
- TAAR
- Vasopressin Receptor
- Glucagon Receptor
- CXCR
- Adenosine Receptor
- Endocrinology & Hormones
- Transmembrane Transporters
-
Metabolism
- PPAR
- P450 (e.g. CYP17)
- HSP (e.g. HSP90)
- PDE
- Hydroxylase
- Factor Xa
- DHFR
- Dehydrogenase
- Procollagen C Proteinase
- Phospholipase (e.g. PLA)
- Carbonic Anhydrase
- MAO
- Liver X Receptor
- FAAH
- IDO
- PKM
- Ferroptosis
- FOX
- Fatty Acid Synthase
- LDL
- GLUT
- Transferase
- Decarboxylase
- FXR
- Vitamin
- Thioredoxin
- HMG-CoA Reductase
- Lipoxygenase
- Lipase
- NAMPT
- CETP
- Casein Kinase
- Retinoid Receptor
- AhR
- AdipoR
- Proteases
- Microbiology
- Others
- Screening Libraries
- FDA-approved Drug Library
- Preclinical and Clinical Compound Library
- Bioactive Compound Library-I
- Bioactive Compound Library-Ⅱ (Provided by Pfizer)
- Kinase Inhibitor Library
- Express-Pick Library (Provided by Pfizer)
- Natural Product Library
- Human Endogenous Metabolite Compound Library
- Angiogenesis Related compound Library
- Antibiotics compound Library
- Anti-cancer Compound Library
- Anti-diabetic Compound Library
- Anti-infection Compound Library
- Apoptosis Compound Library
- Autophagy Compound Library
- Cambridge Cancer Compound Library
- Cell Cycle compound library
- CNS-Penetrant Compound Library
- DNA Damage/DNA Repair compound Library
- Drug Repurposing Library
- Epigenetics Compound Library
- Fragment Library
- GPCR Compound Library
- Histone modification compound library
- HTS Library for Drug Discovery (Provided by Pfizer)
- Immunology/Inflammation Compound Library
- Inhibitor Library
- Ion Channel Ligand Library
- JAK/STAT compound library
- MAPK Inhibitor Library
- Metabolism Compound Library
- Neuronal Signaling Compound Library
- NF-κB Signaling Compound Library
- PI3K/Akt Inhibitor Library
- Protease Inhibitor Library
- Small Molecule Immuno-Oncology Compound Library
- Stem Cell Signaling Compound Library
- Target Selective Inhibitor Library
- TGF-beta/Smad compound library
- Tyrosine Kinase Inhibitor Library
- Therapeutic Antibodies
- New Products
- Contact Us
